Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) Short Interest Update

Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) was the target of a large increase in short interest in December. As of December 31st, there was short interest totalling 2,400 shares, an increase of 20.0% from the December 15th total of 2,000 shares. Based on an average daily volume of 15,700 shares, the short-interest ratio is currently 0.2 days.

Tema Cardiovascular and Metabolics ETF Trading Down 0.7 %

Shares of NASDAQ HRTS traded down $0.19 during trading on Friday, reaching $28.70. The company had a trading volume of 10,235 shares, compared to its average volume of 12,749. Tema Cardiovascular and Metabolics ETF has a twelve month low of $28.56 and a twelve month high of $36.03. The stock has a 50-day moving average price of $30.62 and a two-hundred day moving average price of $32.85. The stock has a market capitalization of $66.30 million, a PE ratio of 32.89 and a beta of 0.93.

Tema Cardiovascular and Metabolics ETF Dividend Announcement

The company also recently announced a dividend, which was paid on Thursday, December 12th. Investors of record on Wednesday, December 11th were paid a $0.4693 dividend. The ex-dividend date was Wednesday, December 11th.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Tema Cardiovascular and Metabolics ETF stock. Sterling Investment Advisors Ltd. increased its position in Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) by 3.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 158,695 shares of the company’s stock after buying an additional 5,605 shares during the period. Tema Cardiovascular and Metabolics ETF comprises 1.4% of Sterling Investment Advisors Ltd.’s portfolio, making the stock its 23rd largest holding. Sterling Investment Advisors Ltd. owned approximately 6.40% of Tema Cardiovascular and Metabolics ETF worth $5,332,000 at the end of the most recent quarter.

Tema Cardiovascular and Metabolics ETF Company Profile

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive.